| Product Code: ETC7765090 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Jordan Neuroblastoma Drug Market Overview |
3.1 Jordan Country Macro Economic Indicators |
3.2 Jordan Neuroblastoma Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Jordan Neuroblastoma Drug Market - Industry Life Cycle |
3.4 Jordan Neuroblastoma Drug Market - Porter's Five Forces |
3.5 Jordan Neuroblastoma Drug Market Revenues & Volume Share, By Mechanism of Action Type, 2021 & 2031F |
3.6 Jordan Neuroblastoma Drug Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.7 Jordan Neuroblastoma Drug Market Revenues & Volume Share, By Diagnosis Type, 2021 & 2031F |
3.8 Jordan Neuroblastoma Drug Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.9 Jordan Neuroblastoma Drug Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 Jordan Neuroblastoma Drug Market Revenues & Volume Share, By End- Users, 2021 & 2031F |
4 Jordan Neuroblastoma Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of neuroblastoma cases in Jordan |
4.2.2 Growing awareness and early diagnosis of neuroblastoma |
4.2.3 Technological advancements in neuroblastoma treatment |
4.3 Market Restraints |
4.3.1 High treatment costs associated with neuroblastoma drugs |
4.3.2 Limited access to specialized healthcare facilities in Jordan |
4.3.3 Stringent regulatory requirements for drug approvals in Jordan |
5 Jordan Neuroblastoma Drug Market Trends |
6 Jordan Neuroblastoma Drug Market, By Types |
6.1 Jordan Neuroblastoma Drug Market, By Mechanism of Action Type |
6.1.1 Overview and Analysis |
6.1.2 Jordan Neuroblastoma Drug Market Revenues & Volume, By Mechanism of Action Type, 2021- 2031F |
6.1.3 Jordan Neuroblastoma Drug Market Revenues & Volume, By Alkylating agents, 2021- 2031F |
6.1.4 Jordan Neuroblastoma Drug Market Revenues & Volume, By Antimetabolites, 2021- 2031F |
6.1.5 Jordan Neuroblastoma Drug Market Revenues & Volume, By Antibiotics, 2021- 2031F |
6.1.6 Jordan Neuroblastoma Drug Market Revenues & Volume, By Microtubule Inhibitors, 2021- 2031F |
6.1.7 Jordan Neuroblastoma Drug Market Revenues & Volume, By Monoclonal Antibodies, 2021- 2031F |
6.2 Jordan Neuroblastoma Drug Market, By Drug Type |
6.2.1 Overview and Analysis |
6.2.2 Jordan Neuroblastoma Drug Market Revenues & Volume, By Cyclophosphamide, 2021- 2031F |
6.2.3 Jordan Neuroblastoma Drug Market Revenues & Volume, By Cisplatin, 2021- 2031F |
6.2.4 Jordan Neuroblastoma Drug Market Revenues & Volume, By Vincristine, 2021- 2031F |
6.2.5 Jordan Neuroblastoma Drug Market Revenues & Volume, By Doxorubicin, 2021- 2031F |
6.2.6 Jordan Neuroblastoma Drug Market Revenues & Volume, By Etoposide, 2021- 2031F |
6.2.7 Jordan Neuroblastoma Drug Market Revenues & Volume, By Topotecan, 2021- 2031F |
6.3 Jordan Neuroblastoma Drug Market, By Diagnosis Type |
6.3.1 Overview and Analysis |
6.3.2 Jordan Neuroblastoma Drug Market Revenues & Volume, By Physical Test, 2021- 2031F |
6.3.3 Jordan Neuroblastoma Drug Market Revenues & Volume, By Urine and Blood Test, 2021- 2031F |
6.3.4 Jordan Neuroblastoma Drug Market Revenues & Volume, By Imaging Test, 2021- 2031F |
6.3.5 Jordan Neuroblastoma Drug Market Revenues & Volume, By Tissue Sample Testing, 2021- 2031F |
6.3.6 Jordan Neuroblastoma Drug Market Revenues & Volume, By Bone Marrow Sample Testing, 2021- 2031F |
6.4 Jordan Neuroblastoma Drug Market, By Treatment Type |
6.4.1 Overview and Analysis |
6.4.2 Jordan Neuroblastoma Drug Market Revenues & Volume, By Surgery, 2021- 2031F |
6.4.3 Jordan Neuroblastoma Drug Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.4.4 Jordan Neuroblastoma Drug Market Revenues & Volume, By Radiotherapy, 2021- 2031F |
6.4.5 Jordan Neuroblastoma Drug Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.4.6 Jordan Neuroblastoma Drug Market Revenues & Volume, By Bone Marrow transplantation, 2021- 2031F |
6.4.7 Jordan Neuroblastoma Drug Market Revenues & Volume, By Retinoid Therapy, 2021- 2031F |
6.5 Jordan Neuroblastoma Drug Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 Jordan Neuroblastoma Drug Market Revenues & Volume, By Oral, 2021- 2031F |
6.5.3 Jordan Neuroblastoma Drug Market Revenues & Volume, By Intravenous and others, 2021- 2031F |
6.6 Jordan Neuroblastoma Drug Market, By End- Users |
6.6.1 Overview and Analysis |
6.6.2 Jordan Neuroblastoma Drug Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 Jordan Neuroblastoma Drug Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6.4 Jordan Neuroblastoma Drug Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6.5 Jordan Neuroblastoma Drug Market Revenues & Volume, By Others, 2021- 2031F |
7 Jordan Neuroblastoma Drug Market Import-Export Trade Statistics |
7.1 Jordan Neuroblastoma Drug Market Export to Major Countries |
7.2 Jordan Neuroblastoma Drug Market Imports from Major Countries |
8 Jordan Neuroblastoma Drug Market Key Performance Indicators |
8.1 Average survival rate of neuroblastoma patients in Jordan |
8.2 Adoption rate of new neuroblastoma drug therapies in the market |
8.3 Number of clinical trials conducted for neuroblastoma drugs in Jordan |
9 Jordan Neuroblastoma Drug Market - Opportunity Assessment |
9.1 Jordan Neuroblastoma Drug Market Opportunity Assessment, By Mechanism of Action Type, 2021 & 2031F |
9.2 Jordan Neuroblastoma Drug Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.3 Jordan Neuroblastoma Drug Market Opportunity Assessment, By Diagnosis Type, 2021 & 2031F |
9.4 Jordan Neuroblastoma Drug Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.5 Jordan Neuroblastoma Drug Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.6 Jordan Neuroblastoma Drug Market Opportunity Assessment, By End- Users, 2021 & 2031F |
10 Jordan Neuroblastoma Drug Market - Competitive Landscape |
10.1 Jordan Neuroblastoma Drug Market Revenue Share, By Companies, 2024 |
10.2 Jordan Neuroblastoma Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here